Short Interest in Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) Increases By 21.5%

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW) was the target of a large growth in short interest in the month of November. As of November 30th, there was short interest totalling 17,500 shares, a growth of 21.5% from the November 15th total of 14,400 shares. Based on an average daily trading volume, of 20,900 shares, the days-to-cover ratio is presently 0.8 days.

Reviva Pharmaceuticals Trading Down 11.3 %

Shares of RVPHW traded down $0.04 during trading hours on Friday, hitting $0.31. The company had a trading volume of 18,848 shares, compared to its average volume of 18,631. Reviva Pharmaceuticals has a one year low of $0.07 and a one year high of $1.62. The company’s fifty day moving average price is $0.17 and its two-hundred day moving average price is $0.18.

Reviva Pharmaceuticals Company Profile

Reviva Pharmaceuticals Holdings, Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for use in the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis.